850429-50-4

Basic information

• Product Name: (TETRAHYDRO-PYRAN-4-YL)-ACETONITRILE
• Synonyms: 4-CYANOMETHYLTETRAHYDROPYRAN;2-(TETRAHYDRO-2H-PYRAN-4-YL)ACETONITRILE;TETRAHYDRO-2H-PYRAN-4-YLACETONITRILE;(TETRAHYDRO-PYRAN-4-YL)-ACETONITRILE;Tetrahydro-2H-pyran-4-ylacetonitrile 95%;2-(Tetrahydro-2H-pyran-4-yl)acetonitrile ,95%;2H-Pyran-4-acetonitrile, tetrahydro-;Tetrahydro-2H-pyran-4-ylacetonitrile95%
• CAS NO: 850429-50-4
• Molecular Formula: C₇H₁₁NO
• Molecular Weight: 125.17
• EINECS: 256-896-0
• Product Categories: blocks;Carboxes;Heterocycles
• Mol File: 850429-50-4.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 83-85/0.5mm
• Flash Point: 101.8℃
• Appearance: /
• Density: 0.974
• Vapor Pressure: 0.03mmHg at 25°C
• Refractive Index: 1.441
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: (TETRAHYDRO-PYRAN-4-YL)-ACETONITRILE(CAS DataBase Reference)
• NIST Chemistry Reference: (TETRAHYDRO-PYRAN-4-YL)-ACETONITRILE(850429-50-4)
• EPA Substance Registry System: (TETRAHYDRO-PYRAN-4-YL)-ACETONITRILE(850429-50-4)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• Hazardous Substances Data: 850429-50-4(Hazardous Substances Data)

Usage

Chemical Properties

Colorless liquid

InChI:InChI=1/C7H11NO/c8-4-1-7-2-5-9-6-3-7/h7H,1-3,5-6H2

Upstream product

• 125552-89-8 4-(bromomethyl)tetrahydro-2H-pyran 
• 151-50-8 potassium cyanide 
• 85064-61-5 2-(tetrahydro-2H-pyran-4-yl)acetic acid 
• 1624363-23-0 3-azido-2-methylbut-3-en-2-ol 
• 1768-64-5 4-chlorotetrahydro-2H-pyran 
• 204651-40-1 2-(tetrahydro-4H-pyran-4-ylidene)acetonitrile 
• 29943-42-8 Tetrahydro-4H-pyran-4-one 
• 14774-37-9 (tetrahydro-2H-pyran-4-yl)methanol 

Downstream Products

• 65412-03-5 4-(2-aminoethyl)tetrahydropyran 
• 85064-61-5 2-(tetrahydro-2H-pyran-4-yl)acetic acid 

Relevant articles and documents

TREATMENT OF CD151 RELATED DISORDERS

The present invention relates to a method of treating a condition in a human related to CD151 the method comprising administering a therapeutically effective amount of a compound of Formula (I):

METHODS OF PROPHYLAXIS AND TREATMENT OF CORONA VIRUS

The present invention relates to a method of prophylaxis or treatment of Corona virus infection in a subject the method comprising administering to the subject a therapeutically effective amount of a compound of Formula (I):

TREATMENT OF VETERINARY CONDITIONS ASSOCIATED WITH CD151

The present invention relates to a method of treating a condition related to CD151 in a non-human animal, the method comprising administering a therapeutically effective amount of a compound of Formula (I): Formula (I)